Join Dr. Richard J. Unger, Founder and CEO of RUSKID LLC, for an eye-opening discussion on medical innovation, clinician entrepreneurship, and addressing critical healthcare gaps that hide in plain sight. In high-stakes environments like the operating room and surgical ICU, patient safety depends on continuous, accurate physiological monitoring. Yet, essential clinical concepts can often disappear for decades—leaving clinicians to work around legacy limitations. Drawing on nearly 40 years of medical leadership, including serving as Chief of Staff and Chairman of Anesthesiology at Scripps Memorial Hospital La Jolla and Co-Director of the Surgical ICU at UC San Diego, Dr. Unger shares the journey of turning a long-overlooked clinical question into a venture-backed medical device startup.

🎯 Insights You’ll Learn:

The Overlooked Problem Paradox: How critical medical ideas and safety mechanisms can disappear from clinical practice for over 20 years despite an unresolved clinical need.

The Clinician-to-Founder Transition: Why frontline physicians have an unmatched advantage in identifying high-impact clinical problems and turning bedside observations into scalable ventures.

Next-Gen Airway Intelligence: How RUSKID is engineering smart airway devices to deliver critical, real-time patient monitoring directly in the operating room.

Protecting the Workflow: The design philosophy required to build smart medical hardware that improves patient outcomes without adding friction, cognitive overload, or extra steps for anesthesiologists.

From Bedside Insight to IP & Prototypes: The operational steps behind protecting proprietary intellectual property, building multidisciplinary engineering teams, raising capital, and navigating preclinical prototypes.

Pathway to Clinical Validation: Navigating the complex regulatory, clinical validation, and hospital commercialization pipelines required to bring new Class II medical devices into standard surgical care.

🌍 Why This Matters: Medical technology often suffers from a fundamental disconnect: engineers build complex diagnostic tools in isolation, while clinicians must manage fast-paced operating room workflows with cumbersome equipment. Dr. Richard Unger is bridging this divide. By leveraging four decades of high-acuity clinical experience, Dr. Unger and the RUSKID team are proving that the best medical innovations do not disrupt workflow—they seamlessly integrate into existing clinical routines to elevate patient safety standards worldwide.

👤 Expert Background:

Founder & CEO of RUSKID LLC, a medical technology company developing proprietary smart airway devices designed for advanced operating room patient monitoring.

Double Board-Certified Physician in Internal Medicine and Anesthesiology, with nearly 40 years of high-acuity surgical and critical care experience.

Former Chief of Staff & Chairman of Anesthesiology at Scripps Memorial Hospital La Jolla, leading clinical quality and medical operations.

Former Co-Director of the Surgical ICU at UC San Diego, specializing in critical care and complex airway management.

🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders navigating the realities of building in the AI era.

💡 Perfect For: MedTech founders, anesthesiologists, surgical directors, healthcare venture capital investors, medical device engineers, and clinical entrepreneurs looking to commercialize medical IP.

🚀 Timely Topic: As surgical suites demand higher-fidelity patient monitoring without increasing provider burnout or workflow complexity, smart, integrated medical hardware represents the future of perioperative care. Dr. Richard Unger delivers the exact blueprint for translating bedside clinical needs into viable medical technologies.

Join Andreas Walbrodt, CEO and Co-Founder of enclaive, for an essential exploration of cybersecurity, data sovereignty, and business confidentiality in an increasingly cloud-reliant world. While enterprises have spent decades securing data at rest (in storage) and in transit (over networks), sensitive workloads remain completely unencrypted the moment they are processed in memory. As organizations rush to adopt public cloud platforms, scale Industry 4.0 smart manufacturing, and deploy proprietary AI models, this "in-use" vulnerability creates catastrophic exposure to cloud operator access, third-party subpoenas, and cyber threats. Drawing on over 30 years of enterprise IT leadership at IBM and TÜV Rheinland, Andreas explains how confidential computing closes this gap—allowing businesses to leverage hyper-scale cloud power without sacrificing sovereignty, compliance, or core intellectual property.

🎯 Insights You’ll Learn:

The "Data-in-Use" blindspot: Why traditional encryption falls short when executing AI inference, RAG pipelines, or processing proprietary Industry 4.0 telemetry.

Demystifying Confidential Computing: How hardware-based trusted execution environments (TEEs) and hardware memory encryption protect data during active computation—even from cloud admins or hosting providers.

Zero-Code Refactoring Cloud Migration: Inside enclaive’s Multi-Cloud Platform (eMCP) that enables "lift-and-shift" confidential VMs, Kubernetes clusters, and AI workloads without rewriting application code or replacing hardware.

Navigating European Digital Sovereignty: How confidential execution aligns with stringent EU regulations like NIS2, DORA, GDPR, and the BSI C5 framework while insulating companies from third-country extra-territorial access.

Protecting AI Models and Prompts: Running enterprise AI algorithms, private fine-tuning, and LLM inference across public cloud GPUs while keeping the underlying model weights and customer data completely private.

From Hardware Silos to Multi-Cloud Trust: Moving away from rigid, expensive Hardware Security Modules (HSMs) to customer-held encryption keys and cryptographic runtime attestations.

🌍 Why This Matters:

The modern enterprise faces a steep dilemma: lock intellectual property inside expensive, rigid on-premise data centers, or migrate to public clouds and risk regulatory non-compliance, data leaks, and lost operational control. For highly regulated sectors like financial services, healthcare, critical infrastructure, and advanced manufacturing, this tradeoff halts innovation. Andreas Walbrodt is solving this fundamental trust gap. By turning confidential computing into a practical software layer that deploys across any cloud provider in days, enclaive gives enterprises absolute cryptographic proof that their secrets remain strictly their own.

👤 Expert Background:

CEO & Co-Founder of enclaive, a Frankfurt/Berlin-based deep-tech cybersecurity company pioneering multi-cloud confidential computing platforms.

30+ Year Enterprise Tech Strategist, having held senior leadership roles driving cloud innovation and data security at IBM and TÜV Rheinland.

European Digital Sovereignty Contributor, active voice in the European cybersecurity ecosystem and contributor to European Cybersecurity Mapping initiatives.

Award-Winning Industry Innovator, leading enclaive through its €4.1M Seed round backed by Join Capital, Amadeus APEX Technology Fund.

🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders navigating the realities of building in the AI era.

💡 Perfect For:

Chief Information Security Officers (CISOs), Chief Technology Officers, Cloud Architects, Enterprise Compliance Officers, Industrial IoT Directors, and AI/ML Operations leaders navigating multi-cloud security and digital sovereignty.

Join Denis Yurchenko, Founder and CEO of MTLAB and creator of Uverest, for an insider look at the fundamental shift transforming global retail infrastructure. For thirty years, e-commerce personalization—from Amazon search rankings to social media feeds—has been paid for by the seller, making the consumer the product rather than the customer. Amazon's $50 billion annual ad business represents a tax on product relevance, forcing consumers to navigate sponsored listings and broken checkout funnels. Denis breaks down why traditional Web architecture fails AI agents, how Uverest provides a buyer-loyal data and checkout layer, and why incumbent marketplace giants cannot copy buyer-aligned AI without destroying their core business models.

🎯 Insights You’ll Learn:

The Buyer-Loyalty Principle: Why true AI shopping agents must work exclusively for the consumer rather than accepting affiliate payouts or sponsored ranking bids.

The Ad-Tax Cannibalization Paradox: Why legacy e-commerce platforms like Amazon cannot deploy genuinely neutral shopping agents without destroying multi-billion-dollar advertising P&Ls.

Overcoming Web-Scraping Structural Failure: Why unstructured web pages—laden with embedded image text, deceptive stock counts, and CAPTCHA walls—cause autonomous agents to fail at checkout.

Uverest’s OS Architecture: How Uverest serves as a buyer-loyal API layer connecting LLM agents directly to store inventory feeds with real-time stock and dynamic visual try-ons.

Native In-Chat Purchase Rails: Bypassing traditional carts, 3D-Secure hurdles, and cookie tracking to execute native transactions directly within the chat interface.

The Sunset of Affiliate Links: Why the $12 billion affiliate marketing industry breaks when AI agents perform discovery and purchasing without human click-throughs.

The 2030 Commerce Landscape: How brick-and-mortar retailers and online brand stores will transition into automated backend fulfillment nodes serving autonomous AI buyers.

🌍 Why This Matters: The global e-commerce ecosystem was engineered for human eyeballs, relying on visual impulse triggers, endless browser tabs, and manual checkout forms. As consumer shopping migrates directly into conversational AI interfaces, raw web scraping fails to deliver reliable purchasing outcomes. Denis Yurchenko is building the necessary plumbing for this transition. By unifying 15,000+ brands and 3 million+ products into a clean, machine-readable data layer backed by AWS, NVIDIA Inception, and the NRF Innovation Lab, Uverest ensures AI agents can find accurate, unbiased products and complete purchases in a single tap.

👤 Expert Background:

Founder & CEO of MTLAB & Uverest, the underlying operating system powering buyer-loyal agentic commerce and automated checkout rails.

25-Year Retail Infrastructure Veteran, who previously built high-scale data analytics platforms for global retail giants including IKEA, DHL, Auchan, and major European e-commerce operators.

Successful Serial Founder, who scaled and successfully exited his previous retail analytics enterprise in 2023 before founding MTLAB in Dubai.

Backed by Premier Tech Coalitions, leading a 10-person team (including 2 PhDs) supported by AWS, NVIDIA Inception, and the National Retail Federation (NRF) Innovation Lab.

🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders navigating the realities of building in the AI era.

💡 Perfect For: E-commerce executives, retail technology directors, AI agent developers, venture capital investors in consumer tech, and brand strategists preparing for the transition from digital storefronts to agentic supply networks.

Join Rutvika Acharya Olofsson, Co-Founder and CEO of Caplyzer, for a candid exploration of deeptech venture building in an era obsessed with fast software iteration. In a market where artificial intelligence enables founders to build, package, and monetize software products in a matter of hours, hardware deeptech faces a fundamentally different reality: multi-year R&D cycles, physical supply chain constraints, and high capital intensity. Drawing from her international career as an aerospace engineer leading product strategy across Sweden, the US, Liechtenstein, and Singapore—as well as her experience building and closing her first startup, MOAI—Rutvika shares why software speed cannot replace physical infrastructure when it comes to solving humanity's largest industrial challenges.

🎯 Insights You’ll Learn:

Hardware DeepTech vs. Instant AI Iteration: Navigating the widening divergence between instant software ROI and long-horizon deeptech capital deployments—and why physical atoms remain the ultimate moat.

Why the Green Hydrogen Market Is Broken Today: The hidden unit-economic and safety barriers holding back global adoption—specifically how legacy electrolyzers rely on expensive membranes, scarce rare-earth metals (like iridium and platinum), and face severe gas-mixing explosion risks.

The Membrane-Free, Decoupled Breakthrough: How Caplyzer’s KTH spin-off technology uses super-capacitive, decoupled water splitting to produce hydrogen and oxygen separately without costly, fragile membranes or precious metal catalysts.

Decarbonizing Heavy Industry for Net Zero: Why electrification alone cannot fix steel, fertilizer, or heavy chemicals, and why cost-effective green hydrogen is non-negotiable for industrial net-zero targets.

The Resilience of a Second-Time Founder: Key lessons from scaling and closing MOAI (an international talent onboarding platform), pivoting into deeptech leadership, and raising institutional backing from Trio Impact Invest, Almi Invest, and KTH Ventures.

Scaling DeepTech While Growing a Family: The personal reality of securing venture funding, navigating top-tier European recognition (KPMG Global Tech Innovator finalist, EU-Startups Top 15), and leading a high-growth startup while pregnant and welcoming her first child.

🌍 Why This Matters:

While generative AI can optimize digital workflows, it cannot split a water molecule or decarbonize a steel plant. Heavy industry accounts for over 30% of global greenhouse emissions, and over 90% of current industrial hydrogen is still produced using fossil fuels (gray/black hydrogen). Rutvika Acharya Olofsson is tackling this structural roadblock head-on. By commercializing Caplyzer’s novel membrane-free, earth-abundant electrolyzers, she is lowering green hydrogen production costs by up to 30%, making clean energy economically compelling for heavy industrial adoption.

👤 Expert Background:

Co-Founder & CEO of Caplyzer, the Swedish KTH spin-off developing next-generation, membrane-free electrolyzers for cost-effective green hydrogen.

Former Aerospace Engineer & Corporate Strategist, with over a decade of global hardware development and product leadership across Sweden, the US, Liechtenstein, and Singapore.

Second-Time Entrepreneur, previously founder of MOAI (Venture Cup Game Changer award winner and Top 10 Young Idea in Sweden).

Recognized DeepTech Leader, named among EU-Startups' top companies to watch and top finalists in the KPMG Global Tech Innovator competition.

🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders navigating the realities of building in the AI era.

💡 Perfect For:

CleanTech and DeepTech investors, climate engineers, energy sector directors, industrial sustainability officers, hardware founders.

Join Michelle Wiltse, Founder and CEO of CompanAIn, for a grounded discussion on why the tech industry’s rush toward "AI-first" branding often undermines true enterprise value. In a market flooded with companies rushing to wrap basic wrapper interfaces around large language models, Michelle took a radically different path. Having previously led agentic AI capabilities and deployed multi-agent systems for major global institutions, she chose to apply this frontier technology where it matters most: eliminating health data fragmentation for companion animals nationwide. In this episode, Michelle shares why the smartest AI strategy prioritizes deliberate restraint—using AI only where it solves genuine structural problems—and how a mission-driven mindset beats superficial "AI theater" every time.

🎯 Insights You’ll Learn:

The "AI-First" Trap: Why labeling your company "AI-first" often signals short-term hype rather than sustainable, long-term technical value.

Restraint as a Technical Advantage: Why frontier technology should be deployed selectively to synthesize unstructured, fragmented data rather than attempting to replace human clinical judgment.

The Multi-Agent Architecture for Health: How dedicated, specialized AI agents—modeled after multidisciplinary veterinary care teams—collaborate on tasks like lab parsing, triage, and longitudinal trend analysis.

Building Connected Health Records: Unifying scattered medical histories, point-in-time clinic records, and home health observations into a single, trusted picture for pet owners and vets.

Mission-Driven Discipline vs. Quick Monetization: Tactical lessons on building lean, defensible healthcare infrastructure over chasing superficial feature releases.

From Big Data to Purpose-Driven Founder: How Michelle's career across big data, finance, and global consulting informed her approach to building production-grade, human-centered software.

🌍 Why This Matters:

Companion animal healthcare suffers from severe structural fragmentation. Critical health data sits siloed across different veterinary clinics, diagnostic labs, and everyday home tracking, forcing pet parents and clinicians to make reactive decisions with incomplete information. Michelle Wiltse is fixing this broken continuity of care. By avoiding unnecessary AI add-ons and engineering multi-agent systems designed specifically to connect longitudinal health signals, CompanAIn gives pet owners and care teams the clear, contextual insights needed to catch health issues early and extend the healthy lives of companion animals.

👤 Expert Background:

Founder & CEO of CompanAIn, a healthtech platform creating the connected health record for companion animals using human-centered agentic AI.

Former Enterprise Agentic AI Leader, who helped establish and scale multi-agent system capabilities for global technology consulting firms and financial institutions.

Big Data & Analytics Veteran, with a background spanning Deloitte, Nielsen, and McLagan Data & Analytics.

Advanced Global Academic Credentials, holding a Phi Beta Kappa degree from Clemson University and an MSc in Global Finance from Bayes Business School.

🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders navigating the realities of building in the AI era.

💡 Perfect For:

HealthTech founders, enterprise AI architects, veterinary technology leads, impact investors, and startup leaders who value sustainable infrastructure and engineering restraint over market hype.

🚀 Timely Topic:

As the initial AI hype cycle matures into a demand for measurable, real-world utility, companies built on superficial chat wrappers are falling away. Michelle Wiltse provides the exact product philosophy and technical framework required to build responsible, high-impact platforms.

Join Chris Winquist, Co-Founder and CEO of Groundhawk, for a compelling look at the digitization of critical physical infrastructure. Infrastructure construction remains one of the world's least digitized sectors, where billions of dollars in underground assets—like fiber optic conduits and power lines—are still documented using paper maps, hand scribbles, or delayed post-backfill estimates. Drawing from his career spanning McKinsey, Nokia, radar satellite unicorn ICEYE, and Groundhawk, Chris breaks down how AI-powered spatial intelligence and smartphone 3D photogrammetry allow field crews to capture centimeter-accurate 3D as-built data while trenches are open, solving a decades-old mapping challenge before the dirt goes back in.

🎯 Insights You’ll Learn:

The Paper Dilemma in Construction: Why legacy reliance on analog documentation and manual surveys leads to inaccurate location data, payment disputes, and massive rework.

The €100B Cable Strike Problem: How inaccurate subsurface mapping triggers costly utility strikes, power outages, and expensive delays across global civil engineering projects.

AI Photogrammetry at the Edge: How computer vision algorithms automatically derive cable runs, ducting, and connections directly from raw spatial video feeds.

Real-Time Quality Assurance: Shifting underground documentation from a passive post-project chore into an active, live verification loop before trench backfilling occurs.

Lessons from Satellite Radar to Subsurface Mapping: How Chris's background at satellite SAR unicorn ICEYE shaped his approach to mapping physical reality from space down to buried infrastructure.

Scaling Deep-Tech Infrastructure across Europe: Strategies for building B2B sales momentum and adoption among contractors, network operators, and utilities across 6+ countries.

🌍 Why This Matters: Every year, thousands of critical utility lines are damaged during excavation because nobody knows their precise, sub-surface physical location. Relying on outdated 2D CAD drawings or memory leads to catastrophic utility strikes and millions in wasted capital. Chris Winquist is solving this spatial gap at the moment of creation. By giving excavation crews a simple tool that turns open trenches into verifiable, 3D digital twin assets in real time, Groundhawk protects critical civil networks, accelerates fiber and energy rollouts, and lays the digital groundwork for smart, resilient infrastructure.

👤 Expert Background:

Co-Founder & CEO of Groundhawk, an Espoo-based construction technology startup delivering AI-powered 3D mapping for underground infrastructure.

Former Commercial & Strategy Leader at ICEYE, the Finnish synthetic aperture radar (SAR) satellite unicorn pioneering earth observation technology.

Former Strategy Consultant & Tech Leader, with deep operational experience at McKinsey & Company and Nokia.

M.Sc. in Engineering, holding an advanced degree from Aalto University.

🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders navigating the realities of building in the AI era.

💡 Perfect For: Civil engineering executives, utility asset directors, telecom rollout leads, construction technology investors, GIS/geospatial specialists, and deep-tech founders modernizing legacy analog industries.

🚀 Timely Topic: As nations invest hundreds of billions into upgrading energy grids and expanding fiber broadband networks, old analog documentation methods cannot keep pace. Chris Winquist provides the technical and operational roadmap for capturing real-world coordinates directly from the field.

#ConTech #UndergroundMapping #Groundhawk #3DScanning #SpatialAI #CivilEngineering #ChrisWinquist #GaryFowler #GSDVentureStudios

Join Dr. Kal Patel, CEO and Co-Founder of BrightInsight, for an illuminating masterclass on navigating product-market fit (PMF) inside one of the most complex, highly regulated sectors in global business: healthcare. Every year, life science giants invest billions of dollars developing breakthrough biopharmaceutical therapies, yet nearly 50% of patients with chronic diseases drop off their prescribed medication regimes within the first twelve months. Drawing from his rare vantage point as a physician, former BCG strategist, former head of Amgen’s Digital Health unit, and leader of BrightInsight, Dr. Patel breaks down why traditional "direct-to-consumer" wellness apps repeatedly fail, how to build enterprise software that biopharma giants trust to touch regulated therapies.

🎯 Insights You’ll Learn:

Unlocking PMF in Biopharma: Why finding true product-market fit in regulated healthcare requires solving for three distinct buyers simultaneously.

The $300B Medication Adherence Deficit: How predictive digital interventions, automated onboarding concierges, and real-time patient companion apps prevent early therapy drop-off.

The "Build vs. Buy" Trap in Enterprise Pharma: Why global biopharma companies historically wasted hundreds of millions building custom, one-off apps that failed to scale globally—and why standardized, compliant infrastructure wins.

Predictive Patient Orchestration: How machine learning algorithms analyze behavioral signals to detect therapy discontinuation risks before a patient misses a dose.

Navigating the Global Regulatory Matrix: The engineering architecture required to launch FDA-regulated software and Software as a Medical Device (SaMD) across 40+ countries without re-inventing regional compliance infrastructure.

Real-World Evidence That Scales: How BrightInsight's real-world deployment with global partners like Sanofi and Regeneron demonstrated a measurable 4% decrease in patient discontinuation and real adherence gains.

🌍 Why This Matters:

The healthcare industry is experiencing a profound structural shift: launching a revolutionary drug is no longer enough to guarantee commercial success or optimal patient outcomes. If a patient abandons a life-saving biologic due to daunting self-injection steps, unmanaged side effects, or prior-authorization friction, the science fails. Dr. Kal Patel is building the underlying connective tissue that fixes this broken pipeline. By providing a unified, regulated digital health platform that powers personalized companion apps, digital patient support programs (PSPs), and algorithm-driven interventions,

👤 Expert Background:

CEO & Co-Founder of BrightInsight, the leading regulated digital health patient orchestration platform for global biopharma and medtech.

Founder & Former Head of Amgen's Digital Health Unit, where he established and scaled connected device programs and digital algorithms across a multi-billion-dollar portfolio.

M.D. & MBA, holding a Doctor of Medicine from the University of Chicago Pritzker School of Medicine and an MBA from the Chicago Booth School of Business.

🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders navigating the realities of building in the AI era.

💡 Perfect For:

Biopharma commercial executives, digital health product leads, healthtech venture capital partners, chief medical officers, enterprise software architects, and founders scaling regulated B2B enterprise platforms.

🚀 Timely Topic:

As biopharma companies reevaluate their software investments, point solutions and standalone apps are being replaced by unified, compliant orchestration platforms. Dr. Kal Patel provides the definitive product philosophy and operational execution model needed to bring digital health into main-stage healthcare delivery.

Join Dr. Sylvie Charles Royston, Founder and CEO of Just Date, for an inspiring conversation on leaving clinical medicine to fix the root cause of chronic illness. As a practicing physician at UCSF treating patients suffering from preventable, sugar-driven conditions like type 2 diabetes and fatty liver disease, Sylvie realized that treating symptoms in a hospital clinic wasn't enough—the systemic solution belonged in the grocery aisle. In this episode, we explore how she translated her clinical medical training and culinary roots into an organic, date-based sweetener empire, expanding from her home kitchen into over 6,000 retail doors nationwide.

🎯 Insights You’ll Learn:

The Clinical Pivot: Why seeing the daily public health impact of refined sugar on UCSF patients inspired Dr. Royston to leave a traditional medical career to fix metabolic health at the source.

Immediate Product-Market Fit: The operational journey of moving from small-batch kitchen iterations to landing nationwide distribution in Whole Foods just weeks after launch.

The Science of Date Sweeteners: How whole, upcycled organic dates deliver a low-glycemic, antioxidant-rich alternative that avoids blood sugar spikes without sacrificing taste or culinary performance.

Category Innovation with Chocolate Chips: The strategic decision to disrupt the baking aisle by launching date-sweetened dark chocolate chips, expanding date syrup from a liquid sweetener into a multi-category platform.

🌍 Why This Matters:

Over a third of the U.S. population suffers from pre-diabetes or diabetes, yet most "healthy" sugar alternatives rely on synthetic artificial sweeteners or heavily processed sugar alcohols that disrupt gut health. Dr. Sylvie Charles Royston is solving this nutritional dilemma by turning nutrient-dense dates—a staple of her childhood—into a versatile, clean-label ingredient platform. From launching nationwide distribution to forging strategic partnerships that fuel retail expansion, Just Date proves that food startups can scale rapidly while remaining fiercely committed to metabolic health, clean ingredients, and sustainable food systems.

👤 Expert Background:

Founder & CEO of Just Date, the physician-founded food brand replacing refined sugar with nutrient-rich, date-based sweeteners and confections.

Former UCSF Physician, who specialized in internal medicine and saw firsthand the urgent need for preventative, diet-based health solutions.

National CPG Scale Operator, scaling Just Date into 6,000+ retail locations including Whole Foods, Sprouts, Kroger, and Natural Grocers.

Health & Nutrition Advocate, recognized for pioneering low-glycemic food innovations that support family wellness and long-term metabolic health.

🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders navigating the realities of building in the AI era.

💡 Perfect For:

CPG founders, food and beverage investors, health and wellness advocates, retail buyers, and prospective entrepreneurs looking to scale mission-driven consumer products.

🚀 Timely Topic:

As consumer demand for clean-label, low-sugar ingredients explodes, the future of CPG belongs to brands that combine rigorous science with uncompromised flavor. Dr. Sylvie Charles Royston is delivering the exact product and scaling blueprint driving that global movement.

Subscribe for more global founder conversations from GSD Venture Studios: https://gsdvs.com

#JustDate #HealthFood #CPG #Nutrition #DateSweetener #CleanIngredients #DrSylvieCharles #GaryFowler #GSDVentureStudios

Join Jeroen van Rotterdam, Co-Founder and CEO of Foamlab, for a deep dive into the industrial transition from extracted synthetic foams to bio-fabricated materials grown by nature. Every year, millions of tons of fossil-based plastic foams are manufactured for packaging, insulation, textiles, and automotive components—materials that generate persistent microplastic pollution and are virtually impossible to recycle economically. Jeroen explains why sustainability shouldn't be a trade-off, how white biotechnology yields materials with mechanical properties superior to petrochemical plastics, and how AI-driven bio-process optimization is accelerating the transition from laboratory Petri dishes to pilot-plant production scale.

🎯 Insights You’ll Learn:

The White Biotech Imperative: Why replacing non-degradable polystyrene and polyurethane requires shifting from petroleum extraction to industrial fermentation using microorganisms.

Bacterial Nanocellulose Platform: How bacteria consume simple sugars to synthesize high-purity cellulose networks that can be tuned into soft sponges, flexible textiles, or rigid load-bearing structural foams.

AI-Accelerated Biomaterial Engineering: Utilizing artificial intelligence and neural predictive models to optimize fermentation parameters, strain performance, and structural foam density in days rather than years.

Overcoming the Biotech Scale-Up Bottleneck: Lessons from raising €3 million in growth capital to build a pilot manufacturing plant, transition out of the lab, and navigate high-yield bioreactor engineering.

Lessons from Enterprise Tech to Deep-Tech Biotech: How Jeroen’s executive leadership experience at Citrix, Dell/EMC, and enterprise software startups informs his pragmatic commercial approach to unit economics and beachhead market selection.

🌍 Why This Matters:

Fossil-based foams like expanded polystyrene (Styrofoam) represent a $29 billion global market built on materials that persist in ecosystems for centuries. Merely tweaking traditional plastic formulations is no longer enough; industrial manufacturing requires a fundamental materials reset. Jeroen van Rotterdam and the team at Foamlab—a TU Delft spin-off—are proving that biology can cultivate materials that meet or exceed synthetic performance specs without environmental liabilities. By leveraging white biotech, automated fermentation tuning, and strategic pilot scale-ups, Foamlab provides a clear blueprint for turning greenhouse-intensive supply chains into circular, bio-based loops.

👤 Expert Background:

Co-Founder & CEO of Foamlab, a Netherlands-based biotech startup scaling high-performance, fully compostable bio-based foams grown from bacterial cellulose.

Former Executive Vice President of Engineering, Cloud, and Security at Citrix, and former executive at Dell/EMC.

Serial Tech Entrepreneur & Angel Investor, who previously founded X-Hive (acquired by EMC) and actively supports deep-tech and sustainable materials startups.

🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders navigating the realities of building in the AI era.

💡 Perfect For:

Biotech investors, circular economy directors, materials science researchers, industrial packaging architects, automotive/aerospace supply chain leads, and deep-tech founders navigating pilot facility scale-ups.

🚀 Timely Topic:

As international regulations tighten around single-use plastics and microplastic pollution, the competitive edge belongs to companies that can supply high-performing, bio-fabricated alternatives at industrial scale. Jeroen van Rotterdam is sharing the exact operational and technological framework driving this shift in 2026.

Join Natalie Boll, Founder and CEO of Tribela, for an urgent and essential dialogue on reengineering the foundational blueprint of social media. After over two decades spent producing award-winning media content for CBC, Amazon, HGTV, and the Food Network, Natalie transitioned into technology to foster a healthier digital future. In this episode, we move past the uninspired debate of absolute youth device bans to explore how safety-by-design protocols, membership-backed business models, and humane design choices can co-exist to form a healthy, highly profitable digital environment for children and young people.

🎯 Insights You’ll Learn:

The Attention Economy Detox: Why the traditional, advertising-driven business model inherently prioritizes toxic user engagement and infinite scroll over human wellness.

The Membership Alternative: Moving away from data-harvesting and corporate ad reliance toward clean, subscription-supported digital spaces that remain highly commercially successful.

The Oxford Incubator Playbook: How mapping global safety standards and ethical framework principles alongside Oxford University Innovation built a robust, enterprise-ready platform.

Humane Technology in Practice: Applying core lessons from the Center for Humane Technology, Harvard Business School Online, and Oxford Saïd Business School to actual tech development.

The Art of Storytelling to Tech Strategy: How a 20-year career creating award-winning media landscapes translates into building a highly engaging yet ethical social space.

The Serial Founder Matrix: Lessons on balancing a diverse portfolio that spans cinematic production houses (Athene Films), organic skincare (Matinata), and deep-tech social architecture.

🌍 Why This Matters: In 2026, the psychological impact of algorithmically driven content loops on young minds is a globally recognized crisis. Yet, forcing kids completely offline isolates them from the very spaces where modern connection and creativity live. Natalie Boll refuses to accept that digital isolation or algorithmic exploitation are our only two choices. By constructing Tribela as a premium, membership-supported digital space rather than a data-harvesting machine, Natalie aligns company profitability directly with user peace of mind. Created with deep academic rigor and a mother’s perspective,

👤 Expert Background:

Founder & CEO of Tribela, an alternative, membership-backed social space pioneering safety-by-design for youth and communities.

Award-Winning Executive Producer with a 20-year track record delivering premium storytelling across Amazon, CBC, and international networks.

Oxford University Innovation Alumnus who incubated Tribela alongside leading global academic and ethical technology insights.

Humane Tech Advocate trained via the Center for Humane Technology, Harvard Business School Online, and Oxford Saïd Business School.

🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders navigating the realities of building in the AI era.

💡 Perfect For: EdTech investors, consumer tech product leads, child safety advocates, privacy compliance officers, and founders trying to align deep ethical design with sustainable, recurring subscription revenue.

🚀 Timely Topic: As international governments move closer to enforcing strict social media age limits and youth device regulations, the race is on for alternative, protected connection spaces. Natalie Boll is delivering the blueprint for an online architecture that honors human development instead of exploiting it.

Subscribe for more global founder conversations from GSD Venture Studios: https://gsdvs.com

#DigitalWellbeing #SafetyByDesign #EthicalTech #Tribela